Shenzhen Lifotronic Technology Co (688389 SHG) stock market data APIs

Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blood analyzers, and related testing reagents, serving hospitals, health check-up centers, and third-party medical testing institutions. The company also provides clinical medical solutions, such as intelligent venous thromboembolism (VTE) prevention systems, wound treatment devices, precision medicine equipment, and pain rehabilitation products for medical institutions; dermatological aesthetics, such as pulsed light therapy devices, shock wave therapy devices, laser therapy machines, and other energy-based medical aesthetic equipment; and therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well as offers E-training services. Further, it offers medical and beauty-related products. Additionally, the company exports its products. Shenzhen Lifotronic Technology Co., Ltd. was founded in 2008 and is headquartered in Shenzhen, China.